Pursuant to Regulation 30 and 46 of SEBI (LODR), we hereby confirm that we have uploaded audio recording of the Q2 of FY24 earnings call held on November 14, 2023, on our company website.

pdf

Solara Active Pharma Sciences Ltd.

21 Aug 2023

477.40

-7.94%

Earnings Call

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (LODR), please find enclosed the transcript of the earnings conference call for the quarter ended June 30, 2023, conducted after the meeting of Board of Directors held on August 14, 2023, for your information and records.

pdf

Solara Active Pharma Sciences Ltd.

14 Aug 2023

477.40

-7.94%

Earnings Call

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Pursuant to Regulation 30 and 46 of SEBI (LODR) we wish to inform that we have uploaded audio recording of the Q1 of FY24 earnings call held on August 14, 2023, on our company website.

pdf

Solara Active Pharma Sciences Ltd.

18 May 2023, 07:09PM

477.40

-7.94%

Earnings Call

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended March 31, 2023, conducted after the meeting of Board of Directors held on May 12, 2023, for your information and records.

pdf

Solara Active Pharma Sciences Ltd.

12 May 2023

477.40

-7.94%

Solara Active Pharma Sciences Results Earnings Call for Q4FY23

Conference Call with Solara Active Pharma Sciences Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

Solara Active Pharma Sciences Ltd.

12 May 2023

477.40

-7.94%

Earnings Call

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q4 of FY23 Earnings Call held on May 12, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.

pdf

Solara Active Pharma Sciences Ltd.

01 Feb 2023

477.40

-7.94%

Earnings Call

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclose the transcript of the earnings conference call for the quarter ended December 31, 2022, conducted after the meeting of Board of Directors held on January 25, 2023, for your information and records.

pdf

Solara Active Pharma Sciences Ltd.

25 Jan 2023

477.40

-7.94%

Earnings Call

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …

BSE India

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q3 of FY23 Earnings Call held on January 25, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.

pdf

Is Solara Active Pharma Sciences Ltd. worth buying?

179 Votes:

Buy 79.89%

Sell 13.97%

Hold 6.15%

45.92% Fall from 52W High

High volume+loss today

Solara Active Pharma Sciences Ltd. Earnings/Conference Calls

Solara Active Pharma Sciences Ltd. earnings concalls and investor presentations